>

Dr Reddys Fundamentals

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 25px;;'>DR</div>
RDY -- USA Stock  

USD 40.16  1.93  4.59%

Dr Reddys fundamental analysis lookup allows you to check this and other indicators for Dr Reddys Laboratories Ltd or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Dr Reddys Current Asset Analysis

Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset 
 = 
Cash 
Deposits 
Liquid Assets 
More About Current Asset | All Equity Analysis

Current Dr Reddys Laboratories Ltd Current Asset

1.81 B
ValuationFinancialsBuy or Sell

About Current Asset

Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Compare to competition
In accordance with recently published financial statements Dr Reddys Laboratories Ltd has Current Asset of 1.81 B. This is 16.03% lower than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?Specialty & Generic industry, The Current Asset for all stocks is 80.65% higher than the company.

Dr Reddys Laboratories Fundamental Drivers Relationships

Dr Reddys Laboratories Ltd is rated fifth in z score category among related companies. It is rated below average in net income category among related companies making up about  43,224,074  of Net Income per Z Score.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Dr Reddys Institutional Holders

Current Institutional Investors

Security TypeSharesValue
Royal Bank Of CanadaCommon Shares4.1 M168.2 M
Blackrock IncCommon Shares1.8 M72.1 M
Renaissance Technologies LlcCommon Shares1.7 M69.3 M
Vanguard Group IncCommon Shares1.1 M45.6 M
Dimensional Fund Advisors LpCommon Shares936.4 K38 M
Goldman Sachs Group IncCommon Shares893.5 K36.3 M
Aperio Group LlcCommon Shares743.8 K30.2 M

Dr Reddys Fundamentals

Current Sentiment - RDY

Dr Reddys Laboratories Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Dr Reddys Laboratories Ltd. What is your opinion about investing in Dr Reddys Laboratories Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

GM   
Purchased over 100 shares of
a day ago
Traded for 30.71
ECA   
Purchased over 500 shares of
a day ago
Traded for 3.54
GM   
Purchased over 100 shares of
a day ago
Traded for 30.71
WD   
Purchased over 40 shares of
a day ago
Traded for 66.38
DD   
Purchased over 70 shares of
a day ago
Traded for 43.18
Additionally, take a look at Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.